keyword
https://read.qxmd.com/read/38618144/adjuvant-transarterial-chemoembolization-plus-immunotherapy-for-huge-hepatocellular-carcinoma-a-propensity-score-matching-cohort-study
#1
JOURNAL ARTICLE
Hongwei Huang, Wei Liao, Kaiyue Zhang, Hao Wang, Qi Cheng, Bin Mei
PURPOSE: The prognosis of patients with huge hepatocellular carcinoma (huge HCC, diameter ≥10 cm) is poor owing to the high early recurrence rate. This study aimed to explore the clinical value of postoperative adjuvant transarterial chemoembolization (PA-TACE) plus programmed cell death-1 (PD-1) inhibitors for huge HCC. PATIENTS AND METHODS: Data from consecutive huge HCC patients treated with hepatectomy during June 2017 and July 2022 were retrospectively collected...
2024: Journal of Hepatocellular Carcinoma
https://read.qxmd.com/read/38607725/alcohol-associated-liver-cancer
#2
JOURNAL ARTICLE
Yaojie Fu, Luca Maccioni, Xin Wei Wang, Tim F Greten, Bin Gao
Heavy alcohol intake induces a wide spectrum of liver diseases ranging from steatosis, steatohepatitis, cirrhosis, and hepatocellular carcinoma (HCC). Although alcohol consumption is a well-known risk factor for the development, morbidity, and mortality of HCC globally, alcohol-associated HCC (A-HCC) is poorly characterized compared to viral hepatitis-associated HCC. Most A-HCCs develop post alcohol-associated cirrhosis, but the direct carcinogenesis from ethanol and its metabolites to A-HCC remains obscure...
April 12, 2024: Hepatology: Official Journal of the American Association for the Study of Liver Diseases
https://read.qxmd.com/read/38596684/il-22-signaling-promotes-sorafenib-resistance-in-hepatocellular-carcinoma-via-stat3-cd155-signaling-axis
#3
JOURNAL ARTICLE
Junzhang Chen, Shiran Sun, Hui Li, Xiong Cai, Chidan Wan
INTRODUCTION: Sorafenib is currently the first-line treatment for patients with advanced hepatocellular carcinoma (HCC). Nevertheless, sorafenib resistance remains a huge challenge in the clinic. Therefore, it is urgent to elucidate the mechanisms underlying sorafenib resistance for developing novel treatment strategies for advanced HCC. In this study, we aimed to investigate the role and mechanisms of interleukin-22 (IL-22) in sorafenib resistance in HCC. METHODS: The in vitro experiments using HCC cell lines and in vivo studies with a nude mouse model were used...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38553263/prognostic-benefit-of-preoperative-transarterial-chemoembolization-in-upfront-resectable-large-hepatocellular-carcinoma-a-multicentric-propensity-score-based-analysis-of-european-high-volume-centers
#4
JOURNAL ARTICLE
Fabio Giannone, Emanuele Felli, Federica Cipriani, Bruno Branciforte, Rami Rhaiem, Bader Al Taweel, Raffaele Brustia, Ephrem Salame, Fabrizio Panaro, Daniele Sommacale, Tullio Piardi, Guido Torzilli, Luca Aldrighetti, Catherine Schuster, Patrick Pessaux
BACKGROUND: Hepatocellular carcinoma (HCC) have a dismal prognosis and any effective neoadjuvant treatment has been validated to date. We aimed to investigate the role of neoadjuvant transarterial chemoembolization (TACE) in upfront resectable HCC larger than 5 cm. METHODS: This is a multicentric retrospective study comparing outcomes of large HCC undergoing TACE followed by surgery or liver resection alone before and after propensity-score matching (PSM). RESULTS: A total of 384 patients were included of whom 60 (15...
March 20, 2024: HPB: the Official Journal of the International Hepato Pancreato Biliary Association
https://read.qxmd.com/read/38517689/feasibility-and-safety-of-robotic-liver-resection-for-huge-%C3%A2-10%C3%A2-cm-hepatocellular-carcinoma-in-a-single-centre-a-propensity-score-matched-single-surgeon-study
#5
JOURNAL ARTICLE
Shurui Wu, Liu Boyuan, Tao Zeng, Ben Ma, Zhaoyi Lin, Minggen Hu
BACKGROUND: The applicability of robot-assisted resection for huge hepatocellular carcinoma (HCC) of ≥10 cm remains contentious with limited available data. METHODS: This retrospective analysis involved 337 patients who underwent robotic liver resection for HCC by a single surgeon. Propensity score matching (PSM) was employed to compare perioperative indicators between patients with regular and huge HCC. RESULTS: The regular HCC group exhibited a shorter median operative duration than the huge HCC group...
April 2024: International Journal of Medical Robotics + Computer Assisted Surgery: MRCAS
https://read.qxmd.com/read/38479177/the-double-roles-of-t-cell-mediated-immune-response-in-the-progression-of-masld
#6
REVIEW
Zigan Li, Shujun Wang, Qinchen Xu, Xin Su, Yunshan Wang, Lina Wang, Yong Zhang
Metabolic dysfunction-associated steatotic liver disease(MASLD), formerly known as non-alcoholic fatty liver disease(NAFLD), has become a major cause of chronic liver disease and a significant risk factor for hepatocellular carcinoma, which poses a huge burden on global public health and economy. MASLD includes steatotic liver disease, steatohepatitis, and cirrhosis, and the latter two cause great harm to human health and life, even complicated with liver cancer. Immunologic mechanism plays a major role in promoting its development into hepatitis and cirrhosis...
March 12, 2024: Biomedicine & Pharmacotherapy
https://read.qxmd.com/read/38446377/interactive-model-for-predicting-the-oncological-outcome-of-patients-with-early-stage-huge-hepatocellular-carcinoma-after-hepatectomy-a-multicenter-population-based-study
#7
JOURNAL ARTICLE
Zixiang Chen, Haonan Sun, Pingchuan Ma, Jiangming Chen, Kejun Hu, Hui Hou, Jinliang Ma, Fubao Liu
An interactive model for predicting the oncological outcome of patients with early-stage huge hepatocellular carcinoma (ES-HHCC) after hepatectomy is still lacking. This study was aimed at exploring the independent risk parameters and developing an interactive model for predicting the cancer-specific survival (CSS) of ES-HHCC. Data from patients with ES-HHCC who underwent hepatectomy were collected. The dimensionality of the clinical features was reduced by least absolute shrinkage and selection operator regression and further screened as predictors of CSS by Cox regression...
March 6, 2024: Updates in Surgery
https://read.qxmd.com/read/38215262/feasibility-and-oncologic-efficacy-of-robotic-vs-open-liver-resection-for-large-and-huge-hepatocellular-carcinoma
#8
JOURNAL ARTICLE
Lorenzo Bernardi, Emanuele Balzano, Davide Ghinolfi, Alessandra Cristaudi
No abstract text is available yet for this article.
January 11, 2024: International Journal of Surgery
https://read.qxmd.com/read/38213163/targeting-protein-phosphatases-for-the-treatment-of-chronic-liver-disease
#9
JOURNAL ARTICLE
Yi-Ming Li, Hong-Wei He, Na Zhang
There exists a huge number of patients suffering from chronic liver disease worldwide. As a disease with high incidence and mortality worldwide, strengthening the research on the pathogenesis of chronic liver disease and the development of novel drugs is an important issue related to the health of all human beings. Phosphorylation modification of proteins plays a crucial role in cellular signal transduction, and phosphatases are involved in the development of liver diseases. Therefore, this article summarized the important role of protein phosphatases in chronic liver disease with the aim of facilitating the development of drugs targeting protein phosphatases for the treatment of chronic liver disease...
January 11, 2024: Current Drug Targets
https://read.qxmd.com/read/38191397/a-novel-prognostic-signature-and-therapy-guidance-for-hepatocellular-carcinoma-based-on-steap-family
#10
JOURNAL ARTICLE
Dongxue Fu, Xian Zhang, Yi Zhou, Shanshan Hu
BACKGROUND: The six-transmembrane epithelial antigen of prostate (STEAP) family members are known to be involved in various tumor-related biological processes and showed its huge potential role in tumor immunotherapy. METHODS: Biological differences were investigated through Gene set enrichment analysis (GSEA) and tumor microenvironment analysis by CIBERSORT. Tumor mutation burden (TMB), immunotherapy response and chemotherapeutic drugs sensitivity were estimated in R...
January 8, 2024: BMC Medical Genomics
https://read.qxmd.com/read/38090482/current-tests-for-diagnosis-of-hepatitis-b-virus-infection-and-immune-responses-of-hbv-related-hcc
#11
REVIEW
Wanting Shi, Kang Li, Yonghong Zhang
Chronic hepatitis B virus (HBV) infection is a worldwide public health threat that results in huge morbidity and mortality. Late diagnosis and delayed treatment of HBV infections can cause irreversible liver damages and occurrence of cirrhosis and hepatocellular carcinoma (HCC). Detection of the presence and activity of HBV are the cornerstones of diagnosis and management in HBV related disease. Moreover, comprehensive knowledge of the mechanisms regulating HBV immunobiology is pivotal for managing diseases related with HBV...
2023: Frontiers in Oncology
https://read.qxmd.com/read/38087108/evolution-of-laparoscopic-liver-resection-in-the-last-two-decades-lessons-from-2000-cases-at-a-referral-korean-center
#12
JOURNAL ARTICLE
Gianluca Cassese, Ho-Seong Han, Yoo-Seok Yoon, Jun-Suh Lee, Boram Lee, Hae Won Lee, Jai Young Cho
BACKGROUND AND AIMS: Laparoscopic liver resection (LLR) has evolved to become the standard surgical approach in many referral centers worldwide. The aim of this study was to analyze how LLR evolved at a single high-volume referral center since its introduction, more than two decades ago. METHODS: Data from all consecutive LLR between January 2003 and September 2022 at the Seoul National University Bundang Hospital were analyzed. Perioperative outcomes were compared between three time periods, with major technological innovations considered as landmarks: before introduction of laparoscopic-US and CUSA (2003-2006), before (2006-2015) and after (2015-2022) introduction of high-definition scope...
December 12, 2023: Surgical Endoscopy
https://read.qxmd.com/read/37983785/short-and-long-term-outcomes-after-robotic-versus-open-hepatectomy-in-patients-with-large-hepatocellular-carcinoma-a-multicenter-study
#13
JOURNAL ARTICLE
Xiu-Ping Zhang, Nan Jiang, Lin Zhu, Zhao-Yi Lin, Wei-Xing Guo, Xiong Chen, Yun-Tao Ma, Fan Zhang, Yu-Fu Tang, Zi-Li Chen, Mao-Lin Yan, Zhi-Ming Zhao, Cheng-Gang Li, Wan Yee Lau, Shu-Qun Cheng, Ming-Gen Hu, Rong Liu
BACKGROUND: Robotic hepatectomy (RH) is currently widely accepted and it is associated with some benefits when compared to open hepatectomy (OH). However, whether such benefits can still be achieved for patients with large hepatocellular carcinoma (HCC) remain unclear. This study aimed to evaluate the short- and long-term outcomes of patients undergoing RH or OH. METHODS: Perioperative and survival data from patients with large HCC who underwent RH or OH between January 2010 and December 2020 were collected from eight centers...
November 17, 2023: International Journal of Surgery
https://read.qxmd.com/read/37928536/case-report-successful-conversion-and-salvage-resection-of-huge-hepatocellular-carcinoma-with-portal-vein-tumor-thrombosis-and-intrahepatic-metastasis-via-sequential-hepatic-arterial-infusion-chemotherapy-lenvatinib-plus-pd-1-antibody-followed-by-simultaneous
#14
Xin Luo, Rui-Zhi Chang, Dong Kuang, Mingming Yuan, Gan-Xun Li, Bixiang Zhang, Yan-Jun Wang, Wan-Guang Zhang, Ze-Yang Ding
BACKGROUND: Advanced hepatocellular carcinoma (HCC) shows poor prognosis. Combined hepatic artery infusion chemotherapy (HAIC) and lenvatinib and PD-1 antibody therapy show promising effects in treating advanced HCC, and salvage hepatectomy further promotes the overall survival in patients who were successfully converted after combined therapy. However, salvage major hepatectomy is not always amenable due to insufficient future liver remnant volume (FLV). CASE PRESENTATION: We report the case of a 59-year-old man with a huge HCC as well as multiple intrahepatic foci and portal vein tumor thrombosis at his right hemi-liver...
2023: Frontiers in Immunology
https://read.qxmd.com/read/37900853/laparoscopically-resected-ectopic-hepatocellular-carcinoma-mimicking-subepithelial-tumor-of-stomach-a-case-report
#15
Yong-Eun Park
Ectopic hepatocellular carcinoma (HCC) can be defined as an HCC arising from hepatic parenchyma located in an extrahepatic organ or tissue. Fewer than 100 cases of ectopic liver have been reported. In 30 of these cases, HCC was detected in ectopic tissue. The author describes a case of ectopic HCC mimicking subepithelial tumor (SET) of the stomach successfully treated by laparoscopic resection. This case report also provides a pertinent review of the literature. A 61-year-old male was referred to our department for the management of an intra-abdominal mass found on abdominal computed tomography performed at a local medical center due to a 2-month history of vague abdominal pain...
2023: Case Reports in Oncology
https://read.qxmd.com/read/37803063/clinical-implications-of-rab13-expression-in-pan-cancer-based-on-multi-databases-integrative-analysis
#16
JOURNAL ARTICLE
Xu-Dong Zhang, Zhong-Yuan Liu, Kai Luo, Xiang-Kun Wang, Mao-Sen Wang, Shuai Huang, Ren-Feng Li
Worldwide, cancer is a huge burden, and each year sees an increase in its incidence. RAB (Ras-related in brain) 13 is crucial for a number of tumor types. But more research on RAB13's tumor-related mechanism is still required. This study's goal was to investigate RAB13's function in human pan-cancer, and we have also preliminarily explored the relevant mechanisms. To investigate the differential expression, survival prognosis, immunological checkpoints, and pathological stage of RAB13 in human pan-cancer, respectively, databases of TIMER2...
October 6, 2023: Scientific Reports
https://read.qxmd.com/read/37791067/modified-hepatic-arterial-infusion-chemotherapy-combined-with-lenvatinib-and-camrelizumab-for-advanced-hcc-two-case-reports
#17
Yuan Tian, Wenbiao Jin, Honghua Sun, Dehao Jin, Dongxu Kang, Zhiyu Li, Longzhen Piao
BACKGROUND: Advanced-stage hepatocellular carcinoma (HCC), especially huge HCC or portal vein tumour thrombus (PVTT), is difficult to treat, and the prognosis is poor. The advantages of hepatic artery infusion chemotherapy (HAIC) combined with targeted therapy and immunotherapy for this complex disease are gradually becoming apparent. However, HAIC still has some inevitable disadvantages, such as arterial perfusion therapy requiring a long time, which results in many patients having difficulty completing the procedure...
2023: Journal of Hepatocellular Carcinoma
https://read.qxmd.com/read/37626196/green-synthesized-silver-nanoparticles-mediated-by-fusarium-nygamai-isolate-ajtyc1-characterizations-antioxidant-antimicrobial-anticancer-and-photocatalytic-activities-and-cytogenetic-effects
#18
JOURNAL ARTICLE
Abeer E El-Ansary, Ahmed A A Omran, Heba I Mohamed, Omima M El-Mahdy
Green biosynthesized nanoparticles have a bright future because they can be produced using a method that is more energy-efficient, cost-effective, repeatable, and environmentally friendly than physical or chemical synthesis. In this study, silver nanoparticles (AgNPs) were produced using the Fusarium nygamai isolate AJTYC1. Several techniques were used to characterize the synthesized AgNPs, including UV-Vis spectroscopy, transmission electron microscope, zeta potential analysis, X-ray diffraction analysis, energy dispersive X-ray, and Fourier transform-infrared spectroscopy...
August 26, 2023: Environmental Science and Pollution Research International
https://read.qxmd.com/read/37594129/usp35-promotes-hepatocellular-carcinoma-progression-by-protecting-pkm2-from-ubiquitination%C3%A2-mediated-degradation
#19
JOURNAL ARTICLE
Tao Lv, Bo Zhang, Chenghao Jiang, Qiwen Zeng, Jiayin Yang, Yongjie Zhou
Hepatocellular carcinoma (HCC) is the most frequently diagnosed primary liver cancer with a high mortality rate and imposes a huge burden on patients and society. Recently, ubiquitin‑specific protease 35 (USP35) was found to be involved in cell proliferation and mitosis, but its role in HCC remains largely unknown. The expression of USP35 in HCC and its association with patient prognosis in the study cohort and public databases was analyzed in the present study. The effects of USP35 on the malignant biological behavior of HCC were analyzed by cellular functional experiments...
October 2023: International Journal of Oncology
https://read.qxmd.com/read/37581654/transcatheter-arterial-chemoembolization-using-callispheres-beads-loaded-with-arsenic-trioxide-for-unresectable-large-or-huge-hepatocellular-carcinoma-a-prospective-study
#20
RANDOMIZED CONTROLLED TRIAL
Xuhua Duan, Hao Li, Pengfei Chen, Tao Sun, Donglin Kuang, Huibin Lu, Bingbing Qiao, Zhengjun Fan, Zhuangjian Ren, Xinwei Han
OBJECTIVES: To determine the safety and efficacy of transcatheter arterial chemoembolization with CalliSpheres® beads loaded with arsenic trioxide (CBATO-TACE) in the first-line treatment of patients with large (5 cm ≤ maximum diameter < 10 cm) or huge (maximum diameter ≥ 10 cm) hepatocellular carcinoma (HCC). METHODS: Patients were randomly allocated to the CBATO-TACE group and the conventional transcatheter arterial chemoembolization (cTACE) group...
February 2024: European Radiology
keyword
keyword
78538
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.